SHOX is a pseudoautosomal homeobox transcription factor located on the short arms of both X and Y chrX|Y that plays a fundamental role in skeletal growth and development 1. As a sequence-specific DNA-binding transcription factor, SHOX preferentially binds DNA elements with the sequence 5'-TAATNNNATTA-3' and directly activates NPPB transcription in osteogenic cells, with strongest expression observed in bone marrow fibroblasts 1. SHOX escapes X-inactivation, allowing dosage-dependent effects across sex chromosome X|Y 1. SHOX haploinsufficiency causes multiple skeletal disorders with significant clinical implications. Heterozygous SHOX mutations occur in approximately 50-90% of Leri-Weill dyschondrosteosis cases, 2-15% of idiopathic short stature, and 66% of Turner syndrome patients, making SHOX defects the most common monogenic cause of short stature 2. Homozygous mutations result in Langer mesomelic dysplasia 3. Importantly, SHOX regulatory element alterations, including whole gene duplications lacking complete flanking regulatory elements, can paradoxically produce haploinsufficiency phenotypes 4. Clinically, SHOX gene haploinsufficiency is an FDA-approved indication for recombinant growth hormone therapy in pediatric patients 5, representing an important therapeutic option for improving adult height in affected children 6.